Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.

Ruscitti P, Masedu F, Alvaro S, Airò P, Battafarano N, Cantarini L, Cantatore FP, Carlino G, D'Abrosca V, Frassi M, Frediani B, Iacono D, Liakouli V, Maggio R, Mulè R, Pantano I, Prevete I, Sinigaglia L, Valenti M, Viapiana O, Cipriani P, Giacomelli R.

PLoS Med. 2019 Sep 12;16(9):e1002901. doi: 10.1371/journal.pmed.1002901. eCollection 2019 Sep.

2.

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. eCollection 2019.

3.

Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease.

Lopalco G, Venerito V, Leccese P, Emmi G, Cantarini L, Lascaro N, Di Scala G, Fabiani C, Rigante D, Iannone F.

Ann Rheum Dis. 2019 Aug 10. pii: annrheumdis-2019-215437. doi: 10.1136/annrheumdis-2019-215437. [Epub ahead of print] No abstract available.

PMID:
31401548
4.

Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases.

Ter Haar NM, Eijkelboom C, Cantarini L, Papa R, Brogan PA, Kone-Paut I, Modesto C, Hofer M, Iagaru N, Fingerhutová S, Insalaco A, Licciardi F, Uziel Y, Jelusic M, Nikishina I, Nielsen S, Papadopoulou-Alataki E, Olivieri AN, Cimaz R, Susic G, Stanevica V, van Gijn M, Vitale A, Ruperto N, Frenkel J, Gattorno M; Eurofever registry and the Pediatric Rheumatology International Trial Organization (PRINTO).

Ann Rheum Dis. 2019 Oct;78(10):1405-1411. doi: 10.1136/annrheumdis-2018-214472. Epub 2019 Jul 5.

PMID:
31278138
5.

Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS).

Lucherini OM, Vitale A, Obici L, Sota J, Frediani B, Merlini G, Rigante D, Cantarini L.

Clin Exp Rheumatol. 2019 May 30. [Epub ahead of print] No abstract available.

PMID:
31172924
6.

Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.

Lopalco G, Venerito V, Cantarini L, Emmi G, Salaffi F, Di Carlo M, Tafuri S, Gentileschi S, Di Scala G, Nivuori M, Cacciapaglia F, Galeazzi M, Lapadula G, Iannone F.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):762-767. Epub 2019 Apr 16.

PMID:
31025925
7.

Classification criteria for autoinflammatory recurrent fevers.

Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton J, Arostegui JI, Barron K, Ben-Cherit E, Brogan PA, Cantarini L, Ceccherini I, De Benedetti F, Dedeoglu F, Demirkaya E, Frenkel J, Goldbach-Mansky R, Gul A, Hentgen V, Hoffman H, Kallinich T, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Laxer RM, Livneh A, Obici L, Ozen S, Rowczenio D, Russo R, Shinar Y, Simon A, Toplak N, Touitou I, Uziel Y, van Gijn M, Foell D, Garassino C, Kastner D, Martini A, Sormani MP, Ruperto N; Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2019 Aug;78(8):1025-1032. doi: 10.1136/annrheumdis-2019-215048. Epub 2019 Apr 24. Review.

PMID:
31018962
8.

Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.

Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Sota J, Cavallaro E, Massaro MG, Ruscitti P, Cipriani P, De Marchi G, De Vita S, Emmi G, Ferraccioli G, Frassi M, Gerli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Rigante D, Dagna L, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Apr 2;10:296. doi: 10.3389/fphar.2019.00296. eCollection 2019.

9.

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Bettiol A, Lopalco G, Emmi G, Cantarini L, Urban ML, Vitale A, Denora N, Lopalco A, Cutrignelli A, Lopedota A, Venerito V, Fornaro M, Vannacci A, Rigante D, Cimaz R, Iannone F.

Int J Mol Sci. 2019 Apr 17;20(8). pii: E1898. doi: 10.3390/ijms20081898. Review.

10.

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.

Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, Guerriero S, Orlando I, Iannone F, Frediani B, Angotti R, Messina M, Galeazzi M, Vannozzi L, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):680-683. Epub 2019 Apr 3.

11.

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study.

Bitossi A, Bettiol A, Silvestri E, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Prisco D, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Emmi G.

Mediators Inflamm. 2019 Feb 10;2019:1623847. doi: 10.1155/2019/1623847. eCollection 2019.

12.

Magnetic resonance imaging of the sacroiliac joints in SpA: with or without intravenous contrast media? A preliminary report.

Gentili F, Cantarini L, Fabbroni M, Nigri A, Mazzei FG, Frediani B, Galeazzi M, Volterrani L, Mazzei MA.

Radiol Med. 2019 Mar 13. doi: 10.1007/s11547-019-01016-w. [Epub ahead of print]

PMID:
30868439
13.

The right place of interleukin-1 inhibitors in the treatment of Behçet's syndrome: a systematic review.

Bettiol A, Silvestri E, Di Scala G, Amedei A, Becatti M, Fiorillo C, Lopalco G, Salvarani C, Cantarini L, Soriano A, Emmi G.

Rheumatol Int. 2019 Jun;39(6):971-990. doi: 10.1007/s00296-019-04259-y. Epub 2019 Feb 25. Review.

PMID:
30799530
14.

Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):301-305. Epub 2019 Jan 18.

15.

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

Sota J, Insalaco A, Cimaz R, Alessio M, Cattalini M, Gallizzi R, Maggio MC, Lopalco G, La Torre F, Fabiani C, Pardeo M, Olivieri AN, Sfriso P, Salvarani C, Gaggiano C, Grosso S, Bracaglia C, De Benedetti F, Rigante D, Cantarini L.

Front Pharmacol. 2019 Jan 8;9:1526. doi: 10.3389/fphar.2018.01526. eCollection 2018.

16.

Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.

Lucherini OM, Vitale A, Orlando I, Sota J, Fabiani C, Franceschini R, Simpatico A, Frediani B, Galeazzi M, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):110-115. Epub 2018 Dec 12.

PMID:
30582507
17.

Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy.

Lopalco G, Venerito V, Sota J, Rigante D, Guerriero S, Orlando I, Franceschini R, Favale R, Lapadula G, Castelli B, Frediani B, Galeazzi M, La Torre F, Iannone F, Tosi GM, Fabiani C, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):68-73. Epub 2018 Dec 12.

PMID:
30582503
18.

Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors.

Barone M, Viggiani MT, Anelli MG, Fanizzi R, Lorusso O, Lopalco G, Cantarini L, Di Leo A, Lapadula G, Iannone F.

J Clin Med. 2018 Dec 1;7(12). pii: E504. doi: 10.3390/jcm7120504.

19.

Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review.

Gaggiano C, Rigante D, Sota J, Grosso S, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):11-17. doi: 10.1007/s10067-018-4361-2. Epub 2018 Nov 28. Review.

PMID:
30488366
20.

An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor-associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome.

Federici S, Vanoni F, Ben-Chetrit E, Cantarini L, Frenkel J, Goldbach-Mansky R, Gul A, Hoffman H, Koné-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Martini A, Obici L, Ozen S, Simon A, Hofer M, Ruperto N, Gattorno M; Eurofever and the Pediatric Rheumatology International Trials Organization (PRINTO).

J Rheumatol. 2019 Apr;46(4):429-436. doi: 10.3899/jrheum.180056. Epub 2018 Nov 1.

PMID:
30385706
21.

Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.

Lucherini OM, Lopalco G, Cantarini L, Emmi G, Lopalco A, Venerito V, Vitale A, Iannone F.

Immunol Lett. 2018 Sep;201:38-44. doi: 10.1016/j.imlet.2018.10.013. Epub 2018 Oct 29.

PMID:
30385329
22.

Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease.

Lopalco G, Venerito V, Cantarini L, Emmi G, Prisco D, Iannone F.

Intern Emerg Med. 2019 Aug;14(5):719-722. doi: 10.1007/s11739-018-1970-3. Epub 2018 Oct 25. No abstract available.

PMID:
30361849
23.

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.

Vitale A, Emmi G, Lopalco G, Fabiani C, Gentileschi S, Silvestri E, Di Scala G, Iannone F, Frediani B, Galeazzi M, Lapadula G, Rigante D, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):267. doi: 10.1007/s10067-018-4302-0.

PMID:
30242638
24.

The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Di Scala G, Sota J, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2018 Aug 27:1-7. doi: 10.1080/09273948.2018.1511810. [Epub ahead of print]

PMID:
30148652
25.

Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.

Gentileschi S, Vitale A, Rigante D, Lopalco G, Emmi G, Orlando I, Di Scala G, Sota J, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Iannone F, Cantarini L.

Isr Med Assoc J. 2018 Jul;20(7):438-441.

26.

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients.

Fabiani C, Vitale A, Rigante D, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Gentileschi S, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.

Clin Rheumatol. 2019 Feb;38(2):407-415. doi: 10.1007/s10067-018-4228-6. Epub 2018 Aug 11.

PMID:
30099655
27.

Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.

Sota J, Vitale A, Rigante D, Orlando I, Lucherini OM, Simpatico A, Lopalco G, Franceschini R, Galeazzi M, Frediani B, Fabiani C, Tosi GM, Cantarini L.

Isr Med Assoc J. 2018 Aug;20(8):517-521.

28.

Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.

Iannone F, Salaffi F, Fornaro M, Di Carlo M, Gentileschi S, Cantarini L, Lopalco G.

Eur J Clin Invest. 2018 Nov;48(11):e13013. doi: 10.1111/eci.13013. Epub 2018 Aug 23.

PMID:
30079593
29.

In silico validation of the Autoinflammatory Disease Damage Index.

Ter Haar NM, van Delft ALJ, Annink KV, van Stel H, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, Benseler S, Brogan PA, Cantarini L, Cattalini M, Cochino AV, de Benedetti F, Dedeoglu F, de Jesus AA, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Kone-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Özen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Schulert G, Gattorno M, Frenkel J.

Ann Rheum Dis. 2018 Nov;77(11):1599-1605. doi: 10.1136/annrheumdis-2018-213725. Epub 2018 Aug 4.

PMID:
30077992
30.

Clodronate in the management of different musculoskeletal conditions.

Frediani B, Giusti A, Bianchi G, Dalle Carbonare L, Malavolta N, Cantarini L, Saviola G, Molfetta L.

Minerva Med. 2018 Aug;109(4):300-325. doi: 10.23736/S0026-4806.18.05688-4. Review.

31.

Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases.

Emmi G, Urban ML, Imazio M, Gattorno M, Maestroni S, Lopalco G, Cantarini L, Prisco D, Brucato A.

Curr Cardiol Rep. 2018 Jun 14;20(8):61. doi: 10.1007/s11886-018-1007-6. Review.

PMID:
29904899
32.

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study.

Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Gentileschi S, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Angotti R, Messina M, Tosi GM, Rigante D, Cantarini L; “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology).

Clin Rheumatol. 2018 Aug;37(8):2233-2240. doi: 10.1007/s10067-018-4119-x. Epub 2018 May 17.

PMID:
29770930
33.

Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies.

Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2018 Oct;37(10):2805-2809. doi: 10.1007/s10067-018-4133-z. Epub 2018 May 15.

PMID:
29766375
34.

The eye involvement in monogenic autoinflammatory diseases: literature review and update.

Sota J, Vitale A, Fabiani C, Frediani B, Rigante D, Tosi GM, Zannin ME, Cantarini L.

Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):44-53. Epub 2018 May 3. Review.

35.

Musculoskeletal manifestations in hereditary periodic fever syndromes.

Soliani M, Cattalini M, Vitale A, Sota J, Cantarini L.

Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):25-31. Epub 2018 May 3. Review.

36.

Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases.

Lucherini OM, Rigante D, Sota J, Fabiani C, Obici L, Cattalini M, Gattorno M, Cantarini L.

Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):3-9. Epub 2018 May 3. Review.

37.

Correction to: A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.

Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R; for EUROFEVER and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Pediatr Rheumatol Online J. 2018 Apr 23;16(1):29. doi: 10.1186/s12969-018-0241-1.

38.

Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement.

Emmi G, Vitale A, Silvestri E, Boddi M, Becatti M, Fiorillo C, Fabiani C, Frediani B, Emmi L, Di Scala G, Goldoni M, Bettiol A, Vaglio A, Cantarini L, Prisco D.

Arthritis Rheumatol. 2018 Sep;70(9):1500-1507. doi: 10.1002/art.40531. Epub 2018 Jul 19.

39.

Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, di Scala G, Guerriero S, Orlando I, Franceschini R, Capozzoli M, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2018 Jun;37(6):1715-1720. doi: 10.1007/s10067-018-4092-4. Epub 2018 Apr 18.

PMID:
29671190
40.

Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.

Brucato A, Emmi G, Cantarini L, Di Lenarda A, Gattorno M, Lopalco G, Marcolongo R, Imazio M, Martini A, Prisco D.

Intern Emerg Med. 2018 Jun;13(4):475-489. doi: 10.1007/s11739-018-1842-x. Epub 2018 Apr 9. Review.

PMID:
29633070
41.

Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.

Fabiani C, Vitale A, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Capozzoli M, Fusco F, Rana F, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):63-70. doi: 10.1007/s10067-018-4069-3. Epub 2018 Apr 3.

PMID:
29611087
42.

Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups.

Feist E, Quartier P, Fautrel B, Schneider R, Sfriso P, Efthimiou P, Cantarini L, Lheritier K, Leon K, Karyekar CS, Speziale A.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):668-675. Epub 2018 Mar 2.

43.

A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry.

Gallizzi R, Pidone C, Cantarini L, Finetti M, Cattalini M, Filocamo G, Insalaco A, Rigante D, Consolini R, Maggio MC, Civino A, Martino S, Olivieri AN, Fabio G, Pastore S, Mauro A, Sutera D, Trimarchi G, Ruperto N, Gattorno M, Cimaz R.

Pediatr Rheumatol Online J. 2017 Dec 21;15(1):84. doi: 10.1186/s12969-017-0213-x. Erratum in: Pediatr Rheumatol Online J. 2018 Apr 23;16(1):29.

44.

Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis.

Fabiani C, Sota J, Vitale A, Emmi G, Vannozzi L, Bacherini D, Lopalco G, Guerriero S, Venerito V, Orlando I, Franceschini R, Fusco F, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2019;27(1):34-39. doi: 10.1080/09273948.2017.1391297. Epub 2017 Nov 3.

PMID:
29099660
45.

Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.

Jamilloux Y, Lefeuvre L, Magnotti F, Martin A, Benezech S, Allatif O, Penel-Page M, Hentgen V, Sève P, Gerfaud-Valentin M, Duquesne A, Desjonquères M, Laurent A, Rémy-Piccolo V, Cimaz R, Cantarini L, Bourdonnay E, Walzer T, Py BF, Belot A, Henry T.

Rheumatology (Oxford). 2018 Jan 1;57(1):100-111. doi: 10.1093/rheumatology/kex373.

PMID:
29040788
46.

Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.

Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Vannozzi L, Franceschini R, Bacherini D, Frediani B, Galeazzi M, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2019;27(1):58-63. doi: 10.1080/09273948.2017.1351573. Epub 2017 Oct 5.

PMID:
28981395
47.

Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behçet's disease.

Lopalco G, Fabiani C, Venerito V, Lapadula G, Iannone F, Cantarini L.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):130-131. Epub 2017 Sep 7. No abstract available.

PMID:
28980903
48.

Diagnostic Criteria for Adult-Onset Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome.

Cantarini L, Vitale A, Sicignano LL, Emmi G, Verrecchia E, Patisso I, Cerrito L, Fabiani C, Cevenini G, Frediani B, Galeazzi M, Rigante D, Manna R.

Front Immunol. 2017 Aug 24;8:1018. doi: 10.3389/fimmu.2017.01018. eCollection 2017.

49.

Systemic Vasculopathy in a Patient With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome.

Cammelli D, Vitiello G, Troilo A, Comin CE, Cantarini L.

J Clin Rheumatol. 2017 Oct;23(7):395-397. doi: 10.1097/RHU.0000000000000533. No abstract available.

PMID:
28937477
50.

Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma.

Orlando I, Vitale A, Rigante D, Lopalco G, Fabiani C, Cantarini L.

Intern Med J. 2017 Sep;47(9):1086-1088. doi: 10.1111/imj.13538. No abstract available.

PMID:
28891187

Supplemental Content

Loading ...
Support Center